Fine specificity of anti-citrullinated peptide antibodies discloses a heterogeneous antibody population in rheumatoid arthritis

Clinical and Experimental Immunology

Volumn 174, Issue 1, 2013, Pages 10-17

  Goules, J D ^a   Goules, A V ^a   Tzioufas, A G ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Anti citrullinated peptide antibodies (ACPA); Epitopes; Pathogenesis; Rheumatoid arthritis; Synthetic peptides

Indexed keywords

ALPHA ENOLASE; ARGININE DEIMINASE; COLLAGEN TYPE 2; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; EPITOPE; FIBRIN; FILAGGRIN; PEPTIDE ANTIBODY; PEPTIDYL ARGININE DEIMINASE; UNCLASSIFIED DRUG; VIMENTIN;

ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; PURIFICATION; RHEUMATOID ARTHRITIS; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTI-CITRULLINATED PEPTIDE ANTIBODIES (ACPA); EPITOPES; PATHOGENESIS; RHEUMATOID ARTHRITIS; SYNTHETIC PEPTIDES;

AMINO ACID SEQUENCE; ANTIBODY DIVERSITY; ANTIBODY SPECIFICITY; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; CROSS REACTIONS; EPITOPES, B-LYMPHOCYTE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MOLECULAR SEQUENCE DATA; PEPTIDES, CYCLIC; PROTEIN BINDING; SJOGREN'S SYNDROME;

EID: 84883620666     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12145     Document Type: Article

References (46)

1. Tobon GJ, Youinou P, Saraux A. The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. J Autoimmun 2010; 35:10-14.
2. Boissier MC, Semerano L, Challal S, Saidenberg-Kermanac'h N, Falgarone G. Rheumatoid arthritis: from autoimmunity to synovitis and joint destruction. J Autoimmun 2012; 39:222-228.
3. Worthington J. Investigating the genetic basis of susceptibility to rheumatoid arthritis. J Autoimmun 2005; 25:16-20.
4. Hickman-Brecks CL, Racz JL, Meyer DM, LaBranche TP, Allen PM. Th17 cells can provide B cell help in autoantibody induced arthritis. J Autoimmun 2011; 36:65-75.
5. Singh U, Vishwanath A, Verma PK etal. Is rheumatoid factor still a superior test for the diagnosis of rheumatoid arthritis? Rheumatol Int 2010; 30:1115-1119.
6. Willemze A, Toes RE, Huizinga TW, Trouw LA. New biomarkers in rheumatoid arthritis. Neth J Med 2012; 70:392-399.
7. Somers K, Geusens P, Elewaut D etal. Novel autoantibody markers for early and seronegative rheumatoid arthritis. J Autoimmun 2011; 36:33-46.
8. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998; 101:273-281.
9. Nielen MM, van Schaardenburg D, Reesink HW etal. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004; 50:380-386.
10. Rantapaa-Dahlqvist S, de Jong BA, Berglin E etal. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003; 48:2741-2749.
11. Lal P, Su Z, Holweg CT etal. Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment. Arthritis Rheum 2011; 63:3681-3691.
12. Kinloch A, Tatzer V, Wait R etal. Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res Ther 2005; 7:R1421-1429.
13. Sebbag M, Moinard N, Auger I etal. Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins. Eur J Immunol 2006; 36:2250-2263.
14. Vossenaar ER, Despres N, Lapointe E etal. Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther 2004; 6:R142-150.
15. Sanmarti R, Graell E, Perez ML etal. Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis. Arthritis Res Ther 2009; 11:R135.
16. Auger I, Martin M, Balandraud N, Roudier J. Rheumatoid arthritis-specific autoantibodies to peptidyl arginine deiminase type 4 inhibit citrullination of fibrinogen. Arthritis Rheum 2010; 62:126-131.
17. Snir O, Widhe M, Hermansson M etal. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients. Arthritis Rheum 2010; 62:44-52.
18. Lundberg K, Kinloch A, Fisher BA etal. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum 2008; 58:3009-3019.
19. Raats JM, Wijnen EM, Pruijn GJ, van den Hoogen FH, van Venrooij WJ. Recombinant human monoclonal autoantibodies specific for citrulline-containing peptides from phage display libraries derived from patients with rheumatoid arthritis. J Rheumatol 2003; 30:1696-1711.
20. Ioan-Facsinay A, el-Bannoudi H, Scherer HU etal. Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities. Ann Rheum Dis 2011; 70:188-193.
21. Ioan-Facsinay A, Willemze A, Robinson DB etal. Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease. Arthritis Rheum 2008; 58:3000-3008.
22. Snir O, Widhe M, von Spee C etal. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles. Ann Rheum Dis 2009; 68:736-743.
23. Arnett FC, Edworthy SM, Bloch DA etal. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-324.
24. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40:1725.
25. Vitali C, Bombardieri S, Jonsson R etal. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61:554-558.
26. Routsias JG, Tzioufas AG, Moutsopoulos HM. The clinical value of intracellular autoantigens B-cell epitopes in systemic rheumatic diseases. Clin Chim Acta 2004; 340:1-25.
27. Yiannaki EE, Tzioufas AG, Bachmann M etal. The value of synthetic linear epitope analogues of La/SSB for the detection of autoantibodies to La/SSB; specificity, sensitivity and comparison of methods. Clin Exp Immunol 1998; 112:152-158.
28. van de Stadt LA, van der Horst AR, de Koning MH etal. The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia. Ann Rheum Dis 2010; 70:128-133.
29. Hida S, Miura NN, Adachi Y, Ohno N. Influence of arginine deimination on antigenicity of fibrinogen. J Autoimmun 2004; 23:141-150.
30. Iobagiu C, Magyar A, Nogueira L etal. The antigen specificity of the rheumatoid arthritis-associated ACPA directed to citrullinated fibrin is very closely restricted. J Autoimmun 2011; 37:263-272.
31. van Beers JJ, Schwarte CM, Stammen-Vogelzangs J, Oosterink E, Bozic B, Pruijn GJ. The rheumatoid arthritis synovial fluid citrullinome reveals novel citrullinated epitopes in apolipoprotein E, myeloid nuclear differentiation antigen, and beta-actin. Arthritis Rheum 2013; 65:69-80.
32. Drosos AA, Lanchbury JS, Panayi GS, Moutsopoulos HM. Rheumatoid arthritis in Greek and British patients. A comparative clinical, radiologic, and serologic study. Arthritis Rheum 1992; 35:745-748.
33. Perez ML, Gomara MJ, Kasi D etal. Synthesis of overlapping fibrin citrullinated peptides and their use for diagnosing rheumatoid arthritis. Chem Biol Drug Des 2006; 68:194-200.
34. Hansson M, Mathsson L, Schlederer T etal. Validation of a multiplex chip-based assay for the detection of autoantibodies against citrullinated peptides. Arthritis Res Ther 2012; 14:R201.
35. Verpoort KN, Jol-van der Zijde CM, Papendrecht-van der Voort EA etal. Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response. Arthritis Rheum 2006; 54:3799-3808.
36. van der Woude D, Rantapaa-Dahlqvist S, Ioan-Facsinay A etal. Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis. Ann Rheum Dis 2010; 69:1554-1561.
37. Sokolove J, Bromberg R, Deane KD etal. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS ONE 2012; 7:e35296.
38. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011; 365:2205-2219.
39. Behrens M, Trejo T, Luthra H, Griffiths M, David CS, Taneja V. Mechanism by which HLA-DR4 regulates sex-bias of arthritis in humanized mice. J Autoimmun 2010; 35:1-9.
40. Rojas-Villarraga A, Diaz FJ, Calvo-Paramo E etal. Familial disease, the HLA-DRB1 shared epitope and anti-CCP antibodies influence time at appearance of substantial joint damage in rheumatoid arthritis. J Autoimmun 2009; 32:64-69.
41. Svendsen AJ, Hjelmborg JV, Kyvik KO etal. The impact of genes on the occurrence of autoantibodies in rheumatoid arthritis. A study on disease discordant twin pairs. J Autoimmun 2013; 41:120-125.
42. Routsias JG, Kyriakidis N, Latreille M, Tzioufas AG. RNA recognition motif (RRM) of La/SSB: the bridge for interparticle spreading of autoimmune response to U1-RNP. Mol Med 2010; 16:19-26.
43. Routsias JG, Tzioufas AG. B-cell epitopes of the intracellular autoantigens Ro/SSA and La/SSB: tools to study the regulation of the autoimmune response. J Autoimmun 2010; 35:256-264.
44. Penzotti JE, Doherty D, Lybrand TP, Nepom GT. A structural model for TCR recognition of the HLA class II shared epitope sequence implicated in susceptibility to rheumatoid arthritis. J Autoimmun 1996; 9:287-293.
45. Tzioufas AG, Routsias JG. Idiotype, anti-idiotype network of autoantibodies: pathogenetic considerations and clinical application. Autoimmun Rev 2010; 9:631-633.
46. Stea EA, Routsias JG, Clancy RM, Buyon JP, Moutsopoulos HM, Tzioufas AG. Anti-La/SSB antiidiotypic antibodies in maternal serum: a marker of low risk for neonatal lupus in an offspring. Arthritis Rheum 2006; 54:2228-2234.